Allelic Variants of Complement Genes Associated with Dense Deposit Disease
Authors:
- Carla NishimuraCNCarla Nishimura
- Kathy FreesKFKathy Frees
- Michael JonesMJMichael Jones
- Tara MagaTMTara Maga
- Louis M. KatzLKLouis M. Katz
- Yuzhou ZhangYZYuzhou Zhang
- Richard J.H. SmithRSRichard J.H. Smith
- 1 August 2011
- journal article
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 22 (8) , 1551-1559
Abstract
The alternative pathway of the complement cascade plays a role in the pathogenesis of dense deposit disease (DDD). Deficiency of complement factor H and mutations in CFH associate with the development of DDD, but it is unknown whether allelic variants in other complement genes also associate with this disease. We studied patients with DDD and identified previously unreported sequence alterations in several genes in addition to allelic variants and haplotypes common to patients with DDD. We found that the likelihood of developing DDD increases with the presence of two or more risk alleles in CFH and C3. To determine the functional consequence of this finding, we measured the activity of the alternative pathway in serum samples from phenotypically normal controls genotyped for variants in CFH and C3. Alternative pathway activity was higher in the presence of variants associated with DDD. Taken together, these data confirm that DDD is a complex genetic disease and may provide targets for the development of disease-specific therapies.Keywords
This publication has 63 references indexed in Scilit:
- The disease-protective complement factor H allotypic variant Ile62 shows increased binding affinity for C3b and enhanced cofactor activityHuman Molecular Genetics, 2009
- Glomeruli of Dense Deposit Disease contain components of the alternative and terminal complement pathwayKidney International, 2009
- Functions of C5a receptorsJournal of Molecular Medicine, 2009
- 3D structure of the C3bB complex provides insights into the activation and regulation of the complement alternative pathway convertaseProceedings of the National Academy of Sciences, 2009
- Mutations in complement C3 predispose to development of atypical hemolytic uremic syndromeBlood, 2008
- Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndromeBlood, 2008
- Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domainsJournal of Experimental Medicine, 2007
- Deletion of Complement Factor H–Related Genes CFHR1 and CFHR3 Is Associated with Atypical Hemolytic Uremic SyndromePLOS Genetics, 2007
- Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndromeProceedings of the National Academy of Sciences, 2007
- Haploview: analysis and visualization of LD and haplotype mapsBioinformatics, 2004